Physician profile
Jay J Dubowsky
NPI 1285630368
$3,035.10
in general payments reported to CMS, 2019-2025
8 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,027 · 2020: $646 · 2021: $160 · 2022: $298 · 2023: $269 · 2024: $251 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,309.18 | 2019-2024 | Aveir |
| Medtronic Vascular, INC. | $499.00 | 2019-2020 | |
| Medtronic, INC. | $469.60 | 2021-2025 | Cobalt Dr Mri Surescan, Symplicity G3 |
| Boston Scientific Corporation | $363.63 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Kiniksa Pharmaceuticals International, Plc | $135.00 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $122.76 | 2022 | |
| Amgen INC. | $122.19 | 2025 | Repatha |
| Preventice Services, LLC | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Dubowsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.